A prospective multicenter study of visual response-evaluation by cystoscopy in patients undergoing neoadjuvant chemotherapy for muscle invasive urinary bladder cancer
Authors:
Open Access
- 21 November 2021
- journal article
- research article
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 56 (1) , 20-26
Abstract
To evaluate a method of transurethral visual response-staging in patients with urothelial muscle-invasive urinary bladder cancer (MIBC), undergoing neoadjuvant chemotherapy (NAC) and radical cystec...Keywords
Funding Information
- the Swedish Research Council funding for clinical research in medicine (ALF) in Västerbotten, VLL (Bas-ALF/VLL RV-848051)
- the Cancer Research Foundation in Norrland (CFF LP 13-2000)
This publication has 27 references indexed in Scilit:
- Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyEuropean Urology, 2017
- Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancerClinical Immunology, 2017
- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerEuropean Urology, 2017
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent TrendsEuropean Urology, 2017
- Prediction of histological stage based on cystoscopic appearances of newly diagnosed bladder tumoursThe Annals of The Royal College of Surgeons of England, 2016
- Pathological T0 Following Radical Cystectomy with or without Neoadjuvant Chemotherapy: A Useful SurrogateJournal of Urology, 2014
- Epidemiology and Risk Factors of Urothelial Bladder CancerEuropean Urology, 2013
- Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder CancerEuropean Urology, 2012
- Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient DataEuropean Urology, 2005
- Neoadjuvant Cisplatinum Based Combination Chemotherapy in Patients with Invasive Bladder Cancer: A Combined Analysis of Two Nordic StudiesEuropean Urology, 2004